Tumefactive demyelinating lesions: a clinicopathological correlative study.

Tumefactive demyelinating (TDL) lesions are focal zones of demyelination in the central nervous system and they often mimic the neuroimaging features of an intraxial neoplasm. In this report we describe the clinical, neuroimaging and neuropathological features of six cases of TDL. Only in two patients the neuroimaging features in MRI (magnetic resonance imaging) scans were suggestive of TDL while in the other four cases a diagnosis of glioma was suggested. In order to establish a confirmatory diagnosis neuronavigation/stereotactic biopsy was undertaken and the diagnosis of TDL was established in all six cases at histopathology. Two out of six patients did not respond to the conventional corticosteroid therapy and they were treated with plasma exchange. It is being concluded that neuronavigation biopsy, though provide only a small amount of tissue, and is extremely useful in making the diagnosis of TDL.

[1]  R. Garg,et al.  Tumefactive demyelinating lesion: experience with two unusual patients. , 2010, Journal of postgraduate medicine.

[2]  B. Scheithauer,et al.  Pseudoneoplasms of the nervous system. , 2010, Archives of pathology & laboratory medicine.

[3]  M. Singh,et al.  Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy , 2009, Multiple sclerosis.

[4]  Shao-wu Li,et al.  Tumefactive demyelinating lesions: nine cases and a review of the literature , 2009, Neurosurgical Review.

[5]  S. Imbesi,et al.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. , 2007, AJNR. American journal of neuroradiology.

[6]  A Miller,et al.  Diagnosis of Multiple Sclerosis , 1998, Seminars in neurology.

[7]  S. Browd,et al.  Decompressive hemicraniectomy for tumefactive demyelination with transtentorial herniation: observation. , 2006, Surgical neurology.

[8]  B. Radotra,et al.  Demyelinating disease simulating brain tumours: a histopathologic assessment of seven cases. , 2006, Indian journal of medical sciences.

[9]  Daljit Singh,et al.  Recurrent tumefactive demyelination in a child , 2005, Journal of Clinical Neuroscience.

[10]  G. Comi Multiple sclerosis: pseudotumoral forms , 2004, Neurological Sciences.

[11]  H. Panitch,et al.  Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. , 2002, Neurology.

[12]  G. Johnson,et al.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. , 2001, AJNR. American journal of neuroradiology.

[13]  T Ernst,et al.  Physiologic MRI of a tumefactive multiple sclerosis lesion , 1998, Neurology.

[14]  J. Smirniotopoulos,et al.  Tumefactive demyelinating lesions , 1996, Neuroradiology.

[15]  J. Kepes,et al.  Large focal tumor‐like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients , 1993, Annals of neurology.

[16]  C. Given,et al.  The MRI appearance of tumefactive demyelinating lesions. , 2004, AJR. American journal of roentgenology.